• Explore /
  • Poster
  • / Response to neoadjuvant trastuzumab and chemotherapy in ER+ and ER- HER2-positive breast cancers: Gene expression analysis.

Response to neoadjuvant trastuzumab and chemotherapy in ER+ and ER- HER2-positive breast cancers: Gene expression analysis.

Abstract Poster

Authors

null

G. Bianchini

Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

G. Bianchini , A. Prat , M. Pickl , A. Belousov , A. Koehler , V. Semiglazov , W. Eiermann , S. Tjulandin , M. Biakhov , A. Lluch , M. Zambetti , F. J. Vazquez Mazon , J. Baselga , L. Gianni

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2011 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Breast Cancer - HER2/ER

Track

Breast Cancer

Sub Track

HER2+

Clinical Trial Registration Number

ISRCTN86043495

Citation

J Clin Oncol 29: 2011 (suppl; abstr 529)

Abstract #

529

Poster Bd #

18

Abstract Disclosures

Similar Posters

First Author: Maki Tanioka

First Author: P. Gomez Pardo

First Author: Gargi D. Basu

First Author: Anuradha Belur